ABCL - AbCellera Biologics Inc.
AbCellera Biologics Inc.
2215 Yukon Street
Vancouver, BC V5Y 0A1
Canada
https://www.abcellera.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 525
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Dr. Carl L.G. Hansen Ph.D. | CEO, Pres & Chairperson | 711.47k | 1.85M | 1975 |
| Mr. Andrew Booth M.B.A. | Chief Financial Officer | 642.42k | 510.82k | 1974 |
| Dr. Veronique Lecault Ph.D. | COO & Director | 645.07k | N/A | 1985 |
| Mr. Tryn T. Stimart Esq., J.D. | Chief Legal Officer, Chief Compliance Officer & Corp. Sec. | 644.4k | N/A | 1970 |
| Mr. Neil Aubuchon M.B.A. | Chief Commercial Officer | 684.81k | N/A | 1970 |
| Dr. Ester Falconer Ph.D. | Chief Technology Officer | N/A | N/A | 1975 |
| Mr. Bo Barnhart Ph.D. | Scientific Director | N/A | N/A | N/A |
| Ms. Tiffany Chiu B.Sc., Ph.D. | VP of Communications | N/A | N/A | N/A |
| Alexandra Weirich M.Sc. | Mang. of Marketing & Communications | N/A | N/A | N/A |
| Graham Craig M.Sc. | Director of Corp. Devel. | N/A | N/A | N/A |
Description
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Corporate governance
AbCellera Biologics Inc.’s ISS governance QualityScore as of 1 June 2023 is 8. The pillar scores are Audit: 9; Board: 9; Shareholder rights: 4; Compensation: 9.
